These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23650169

  • 1. Fetal safety of macrolides.
    Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, Levy A.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3307-11. PubMed ID: 23650169
    [Abstract] [Full Text] [Related]

  • 2. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
    Daniel S, Matok I, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A.
    J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
    [Abstract] [Full Text] [Related]

  • 3. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.
    Fan H, Gilbert R, O'Callaghan F, Li L.
    BMJ; 2020 Feb 19; 368():m331. PubMed ID: 32075790
    [Abstract] [Full Text] [Related]

  • 4. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A.
    N Engl J Med; 2009 Jun 11; 360(24):2528-35. PubMed ID: 19516033
    [Abstract] [Full Text] [Related]

  • 5. The safety of H(2)-blockers use during pregnancy.
    Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Uziel E, Levy A.
    J Clin Pharmacol; 2010 Jan 11; 50(1):81-7. PubMed ID: 19789371
    [Abstract] [Full Text] [Related]

  • 6. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.
    Lund M, Pasternak B, Davidsen RB, Feenstra B, Krogh C, Diaz LJ, Wohlfahrt J, Melbye M.
    BMJ; 2014 Mar 11; 348():g1908. PubMed ID: 24618148
    [Abstract] [Full Text] [Related]

  • 7. Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study.
    Rotem R, Fishman B, Daniel S, Koren G, Lunenfeld E, Levy A.
    BJOG; 2018 Nov 11; 125(12):1550-1556. PubMed ID: 29790255
    [Abstract] [Full Text] [Related]

  • 8. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.
    Bar-Oz B, Weber-Schoendorfer C, Berlin M, Clementi M, Di Gianantonio E, de Vries L, De Santis M, Merlob P, Stahl B, Eleftheriou G, Maňáková E, Hubičková-Heringová L, Youngster I, Berkovitch M.
    Drug Saf; 2012 Jul 01; 35(7):589-98. PubMed ID: 22702640
    [Abstract] [Full Text] [Related]

  • 9. The safety of macrolides during lactation.
    Goldstein LH, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M.
    Breastfeed Med; 2009 Dec 01; 4(4):197-200. PubMed ID: 19366316
    [Abstract] [Full Text] [Related]

  • 10. The safety of fetal exposure to proton-pump inhibitors during pregnancy.
    Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R.
    Dig Dis Sci; 2012 Mar 01; 57(3):699-705. PubMed ID: 22038541
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy outcome following opioid exposure: A cohort study.
    Fishman B, Daniel S, Koren G, Lunenfeld E, Levy A.
    PLoS One; 2019 Mar 01; 14(7):e0219061. PubMed ID: 31260464
    [Abstract] [Full Text] [Related]

  • 12. Safety of macrolides during pregnancy.
    Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S.
    Am J Obstet Gynecol; 2013 Mar 01; 208(3):221.e1-8. PubMed ID: 23254249
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B, Diav-Citrin O, Shechtman S, Tellem R, Arnon J, Francetic I, Berkovitch M, Ornoy A.
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov 01; 141(1):31-4. PubMed ID: 18760873
    [Abstract] [Full Text] [Related]

  • 14. Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.
    Matok I, Gorodischer R, Koren G, Landau D, Wiznitzer A, Levy A.
    Br J Clin Pharmacol; 2009 Dec 01; 68(6):956-62. PubMed ID: 20002091
    [Abstract] [Full Text] [Related]

  • 15. The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy.
    Daniel S, Doron M, Fishman B, Koren G, Lunenfeld E, Levy A.
    Br J Clin Pharmacol; 2019 Dec 01; 85(12):2856-2863. PubMed ID: 31486528
    [Abstract] [Full Text] [Related]

  • 16. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
    Cooper WO, Ray WA, Griffin MR.
    Obstet Gynecol; 2002 Jul 01; 100(1):101-6. PubMed ID: 12100810
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of macrolides during pregnancy and the risk of birth defects: a population-based study.
    Bérard A, Sheehy O, Zhao JP, Nordeng H.
    Pharmacoepidemiol Drug Saf; 2015 Dec 01; 24(12):1241-8. PubMed ID: 26513406
    [Abstract] [Full Text] [Related]

  • 19. Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway.
    Romøren M, Lindbæk M, Nordeng H.
    Br J Clin Pharmacol; 2012 Dec 01; 74(6):1053-62. PubMed ID: 22463376
    [Abstract] [Full Text] [Related]

  • 20. The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study.
    Shlomo M, Gorodischer R, Daniel S, Wiznitzer A, Matok I, Fishman B, Koren G, Levy A.
    Drug Saf; 2017 Nov 01; 40(11):1147-1155. PubMed ID: 28733971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.